Incretin-based treatment of type 2 diabetes: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.

Carolyn F Deacon

55 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Incretin-based treatment of type 2 diabetes: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.'. Together they form a unique fingerprint.

Medicine & Life Sciences